A Look Back at 2022

"Learn from yesterday, live for today, hope for tomorrow."

- Albert Einstein

To everyone that made this year a success, we extend our sincere thanks. We are excited to greet the new year and all the shared successes still to come!

Commercial Manufacturing at KBI Biopharma

What better location for a state-of-the-art $150 million, 150,000 square-foot commercial manufacturing facility, than Research Triangle Park (RTP), North Carolina?

RTP is a collaborative innovation center at the epicenter of Duke University, North Carolina State University and University of North Carolina Chapel Hill (Tier-1 research universities). Additionally, there are over 300 companies, including science and technology firms, government agencies, academic institutions, startup companies and nonprofits in the area.

“Our new facility allows KBI to remain on the cutting-edge of the latest innovations in automation and digitalization. With the highest quality people, systems, and processes, we intend to be a true center of excellence and an exceptional place to work.”

- Jesse Kingg, Senior VP and Site Head

Now fully operational, KBI Biopharma’s newest facility in this biotech hub supports commercial manufacturing of mammalian-based products.

• Read the Press Release
• Catch the Highlights from the Ribbon Cutting

European Expansion: Integrated Biologics Manufacturing Facility

KBI Biopharma launched an expanded, fully integrated mammalian contract development and manufacturing services facility in Geneva, Switzerland.  In a city with over 200 pharmaceutical, biotech, and medical device companies, this new facility is situated alongside world-renowned pharmaceutical and cutting-edge startup companies.

The ~94,000 square-foot facility builds upon an existing market foothold by combining best-in-class cell line development (CLD) and expert mammalian manufacturing in a single location. Co-located with Selexis SA, the expansion enables industry-leading delivery of client programs through increased quality, efficiency, and time savings with deep expertise across a diverse portfolio of molecule formats.

Together, KBI and Selexis have developed a seamless approach that optimizes the client experience.

• Discover the power of KBI and Selexis in Geneva
• Catch the Highlights from the Ribbon Cutting

 “For today’s scientists, crossing borders between countries and disciplines is instrumental to opening doors to new questions and new answers”

- Emmanuelle Charpentier 

Conferences, Congresses, and In-Person Events

In 2022, we had the pleasure of attending 27 conferences and congresses around the world. We greatly enjoyed connecting with many of our clients, colleagues, and future clients while learning about the latest developments in emerging areas of science and technology. 2023 is shaping up to be even more exciting, and we are looking forward to seeing many of you in the coming year.

Research, Publications, and Resources

Our scientific experts were busy in 2022, communicating their latest research and findings in various publications, tech talks, poster presentations, and webinars throughout the year.

• New Journal Publication: Application of Inline Variable Pathlength Technology for Rapid Determination of Dynamic Binding Capacity in Downstream Process Development of Biopharmaceuticals

• Q&A with KBI’s Scientific Team: Faster Determination of Dynamic Binding Capacity

• Webinar: Development of effective purification processes for bispecifics using affinity capture and mix-mode polishing chromatography

• Whitepaper: Delivering on the Promise of Bispecifics: State-of-the-Art Bispecific Antibody Development

• Tech Talk: Application of Titration Curve Modeling in Bioassay Potency Method Development

• Article: Quality by Design and Affinity Chromatography

• Webinar: Development of effective purification processes for bispecifics using affinity capture and mix-mode polishing chromatography

 "The more we know, the more we realize there is to know" 

- Jennifer Doudna

Stay tuned as additional tech talks, articles, and poster presentations become available. You can subscribe to our newsletter The Pulse to stay up to date on all the latest news and developments that are on their way – together, we’ll make this next year the best one yet!